|

Shared Care Thyroid Cancer Follow-up Utilizing Thyroid Cancer Assessment Reminder System (TCARS) Study - A Pilot Study.

RECRUITINGSponsored by Nova Scotia Health Authority
Actively Recruiting
SponsorNova Scotia Health Authority
Started2022-09-30
Est. completion2025-09-30
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

This study aims to assess the feasibility of a shared-care model for low-risk differentiated thyroid cancer (DTC) patients, primary care practitioners (PCPs) and the tertiary care center utilizing a digital health-based thyroid cancer assessment reminder system (TCARS) in Medable with an expedited referral to specialists for rapid assessment in case of a concern of recurrence.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

Adult (\>18 years old) consenting patients being followed at the Halifax Interdisciplinary Thyroid Oncology Clinic (ITOC) meeting the following criteria:

* AJCC stage 1 DTC with no radiological or biochemical evidence of thyroid cancer with undetectable high sensitivity serum thyroglobulin (hsTG \<0.06 mcg/L\*);
* Anti-thyroglobulin antibody (anti-TG AB \<20 IU/ml\*);
* Thyroid ultrasound scan \[USS\] negative for regional recurrence at least 24 months after most recent treatment;
* AJCC stage 2 DTC with no radiological or biochemical evidence of cancer (undetectable hsTG and anti-TG AB and negative thyroid USS) at least 48 months after most recent treatment
* Patient is comfortable with using the mobile or Medable application and has access to internet.

Exclusion Criteria:

Patient does not have a consented PCP.

Conditions2

CancerLow Risk Differentiated Thyroid Cancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.